机译:Interleukin-15与抗CD40抗体的结合为结肠癌的鼠模型提供了增强的治疗功效
Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 Laboratory Animal Science Program, Science Applications International Corporation, National Cancer Institute, Frederick, MD 21702;
Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
animal model; cancer immunotherapy; IL-15 receptor-α;
机译:促进细胞外基质亲和力提高了类风湿性关节炎鼠模型中抗TNF-α抗体的局部治疗效果
机译:激动性抗CD40抗体疗法可有效抵抗鼠肿瘤模型中的术后癌症复发和转移
机译:肿瘤治疗田间(TTFIELS)诱导的免疫原性细胞死亡增强了肺癌和结肠癌动物模型的抗PD-1治疗时的疗效
机译:SOR-C13,一种靶向TRPV6 oncoChannel的新型癌症肽治疗性靶向鼠模型中的乳腺癌和卵巢癌异种移植物的疗效
机译:一种基于标记抗体的新型技术在小鼠模型中的生物治疗分布和疗效分析
机译:白介素15与抗CD40抗体的结合为结肠癌的鼠模型提供了增强的治疗功效
机译:白介素15与抗CD40抗体的结合为结肠癌的鼠模型提供了增强的治疗功效